董秋美, 郑伟华, 何友. 老年结直肠癌与中青年结直肠癌临床病理特征对比分析 [J]. 南方医科大学学报, 2010, (9):2128.
|
李雅静, 赵春杰, 王晨. 奥沙利铂与胰岛素在葡萄糖注射液中配伍稳定性的考察 [J]. 中国药师, 2010(9):1307.doi: 10.3969/j.issn.1008-049X.2010.09.038.
|
田琳. HPLC法测定注射用奥沙利铂主药含量 [J]. 中外医疗, 2009, (14):14.doi: 10.3969/j.issn.1674-0742.2009.14.009.
|
刘祝东, 栾春芳, 普绍平. 奥沙利铂及其手性异构体的高效液相色谱分析 [J]. 贵金属, 2007(2):50.doi: 10.3969/j.issn.1004-0676.2007.02.011.
|
Luo F R, Yen T Y, Wyrick S D. High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin [J]. Journal of Chromatography B:Biomedical Sciences and Applications, 1999(2):345.
|
Koellensperger G, Hann S. Ultra fast HPLC-ICP-MS analysis of oxaliplatin in patient urine [J]. Analytical Biochemistry, 2010(3):401.
|
Mowaka S, Linscheid M. Separation and characterization of oxaliplatin dinucleotides from DNA using HPLC-ESI ion trap mass spectrometry [J]. Analytical Biochemistry, 2008(5):819.
|
Mowaka S, Ziehe M, Mohamed D. Structures of oxaliplatin-oligonucleotide adducts from DNA [J]. Journal of Mass Spectrometry, 2012, (10):1282.
|
彭书泉, 刘晓华, 崔慧萍. HPLC法测定5氟尿嘧啶氯化钠注射液的含量 [J]. 山东医药工业, 2002(3):16.doi: 10.3969/j.issn.1672-7738.2002.03.018.
|
黎远东, 梁宁生, 陆益. HPLC法测定人体血浆中5-氟尿嘧啶的浓度 [J]. 广西医科大学学报, 2007(6):953.doi: 10.3969/j.issn.1005-930X.2007.06.065.
|
陈碧. HPLC法测定人血清中5氟尿嘧啶浓度 [J]. 医药沙龙, 2005(7):332.doi: 10.3969/j.issn.1001-5094.2005.07.008.
|
张迪, 郭宏伟, 孙宽. HPLC法测定复方氟尿嘧啶注射液含量及有关物质 [J]. 中国药师, 2012(3):356.doi: 10.3969/j.issn.1008-049X.2012.03.026.
|
张枫, 王桥, 宋学英. HPLC测定静脉给药后大鼠血清中5-氟尿嘧啶的含量 [J]. 中国药学杂志, 2002(6):439.doi: 10.3321/j.issn:1001-2494.2002.06.013.
|
BuchelB, RhynP, SehurchS. LC-MS/MS method for simultaneous analysis of uracil, 5, 6-dihydrouracil, 5-fluorouracil and 5-fluoro-5, 6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients [J]. Biomedical Chromatography, 2013(1):7.
|
Chen W L, Shen Y Y, Rong HJ. Development and application of a validated gradient elution HPLC method for simultaneous determination of 5-fluorouracil and paclitaxel in dissolution samples of 5-fluorouracil/paclitaxel-co-eluting stents [J]. Journal of Pharmaceutical and Biomedical Analysis, 2012.179.
|
Han S W, Lee H J, Bae J M. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer [J]. International Journal of Cancer, 2013(9):2209.
|
Rao K M, Mallikarjuna B, Krishna Rao KSV. Synthesis and Characterization of pH Sensitive Poly (Hydroxy Ethyl Methacrylate-co-acrylamidoglycolic Acid) Based Hydrogels for Controlled Release Studies of 5-FluorouracilInternational [J]. J Polym Mat, 2013.565.
|
Icsel C, Yilmaz V T, Ari F. trans-Dichlorido palladium(Ⅰ Ⅰ) and platinum (Ⅱ) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine:Synthe sis, structural characteriz ation, DNA binding and in vitro cytotoxicity studies [J]. European Journal of Medicinal Chemistry, 2013(3):386.
|
Crehange G, Bosset J F, Maingon P. Preoperative radiochemotherapy for rectal cancer:Forecasting the next steps through ongoing and forthcoming studies [J]. Cancer Radiotherapy, 2011(6):440.
|
Nguyen T T, Ostergaard J, Sturup S. Amino acid analysis by using comprehensive two-dimensional gas chromatography [J]. Analytical Biochemistry, 2012(3):2131-2139.
|